SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
anti-bacterial agents / therapeutic use*
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
79
1
Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial
2
Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005
3
Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance
4
Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group
5
Single-dose azithromycin for Chlamydia in pregnant women
6
Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori
7
Comparison of PCR, Fluorescent in Situ Hybridization and Blood Cultures for Detection of Bacteremia in Children and Adolescents During Antibiotic Therapy
8
Antibiotics to prevent infection in patients with dog bite wounds: a meta-analysis of randomized trials
9
Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis
10
Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin
11
Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa
12
The effective period of preventive antibiotic action in experimental incisions and dermal lesions
13
Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease
14
Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection
15
Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus
16
Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976
17
Recurrent erysipelas: 47 cases
18
Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient
19
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
20
A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men
21
Treatment of febrile neutropenia: what is new?
22
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America
23
Probiotics in man and animals
24
Prophylactic and preventive antibiotic therapy: timing, duration and economics
25
Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens
26
A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections
27
Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy
28
Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia
29
Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor
30
Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women
31
Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials
32
Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?
33
Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises
34
Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis
35
Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania
36
Inappropriate antibiotic use in soft tissue infections
37
Penicillin to prevent recurrent leg cellulitis
38
Duodenal infusion of donor feces for recurrent Clostridium difficile
39
Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin
40
Community-acquired bacterial meningitis in adults
41
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis
42
Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study
43
Traumatic cerebrospinal fluid leakage: risk factors and the use of prophylactic antibiotics
44
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia
45
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone
46
Prophylactic oral antibiotics for low-risk dog bite wounds
47
Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up
48
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides
49
Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study
50
Multinational cooperation in trials and guidelines dealing with febrile neutropenia
51
Methicillin-resistant S. aureus infections among patients in the emergency department
52
Approach to the patient with presumed cellulitis
53
Compliance with doxycycline therapy in sexually transmitted diseases clinics
54
Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia. Is there agreement?
55
Managing antibiotic use--impact of infection control
56
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)
57
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial
58
Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee
59
Azithromycin in the treatment of chlamydial cervicitis and eradication of Ureaplasma urealyticum in female lower genital tract
60
Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy
61
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines
62
Challenges in the diagnosis and management of neonatal sepsis
63
Treatment of bubonic plague with sulfonamides and antibiotics
64
Therapeutic drug monitoring of amikacin in septic patients
65
Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis
66
Immediate and long-term efficacy of systemic antibiotics for eradicating nasal colonization with Staphylococcus aureus
67
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections
68
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)
69
Fidaxomicin versus vancomycin for Clostridium difficile infection
70
Determinants of amikacin first peak concentration in critically ill patients
71
Antibiotic prescribing over the last 16 years: fewer antibiotics but the spectrum is broadening
72
Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya
73
Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia
74
Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E
75
Typhoid outbreak in Songkhla, Thailand 2009-2011: clinical outcomes, susceptibility patterns, and reliability of serology tests
76
Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin
77
Lymphatic filariasis and onchocerciasis
78
Old antibiotics for infections in critically ill patients
79
Multidrug-resistant typhoid fever